JNJ vs HUM
By Alex · Tickerpine
Johnson & Johnson vs Humana Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | HUM |
|---|---|---|
| Price | $263.81 | $422.07 |
| Market cap | $635.07B | $50.68B |
| P/E ratio | 40.0 | 39.9 |
| ROE | 20.02% | 6.89% |
| Profit margin | 16.20% | 0.88% |
| Revenue growth | 5.90% | 26.20% |
| Dividend yield | 2.03% | 0.84% |
| Beta | 0.21 | 0.74 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs HUM in plain English
- JNJ is the bigger company — about 12.5× the market cap of HUM.
- HUM is cheaper on earnings (P/E 39.9 vs 40.0).
- JNJ earns a higher return on equity (20% vs 7%).
- HUM is growing revenue faster (26% vs 6%).
- JNJ has the higher dividend yield (2.03% vs 0.84%).
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
HUM return calculator
See what $1,000 in Humana Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.